UNLIMITED TURBO BULL - AMGEN | Market Closed - Euronext Paris 12:30:00 2024-04-26 pm EDT | ||
| 9.5 EUR | +1.82% |
|
| Current month | -13.87% | ||
| 1 month | -11.79% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 9.5 | +1.82% | 87 |
| 24-04-25 | 9.33 | -5.85% | 98 |
| 24-04-24 | 9.91 | +0.30% | 92 |
| 24-04-23 | 9.88 | +1.33% | 87 |
| 24-04-22 | 9.75 | +4.73% | 83 |
Real-time Euronext Paris
Last update April 26, 2024 at 12:30 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| 53U4S | |
| ISIN | DE000SD3KW32 |
| Date issued | 2021-02-04 |
| Strike | 168.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 7.98 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.2 € |
|---|---|
| Lowest since issue | 4.815 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
270
USD
Average target price
300.3
USD
Spread / Average Target
+11.22%
- Stock Market
- Certificates
- 53U4S Certificat
